Theodore J Kottom

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 27

Top Topics

Tyrosine Kinase

Saccharomyces Cerevisiae

Immune Response

Top Venues

Antimicrobial agents and chemotherapy

Medical mycology

Journal of fungi (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Amjad N Kanj, Irene Riestra Guiance, Theodore J Kottom, Kyle J Schaefbauer, Malay Choudhury, Andrew H Limper, Joseph H Skalski
The commensal fungus Wallemia mellicola enhances asthma in mice through Dectin-2. Medical mycology (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Kimberly E Stelzig, Madeline R Pellegrino, Marc Bindzus, Eunhee S Yi, Andrew H Limper
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2). Drugs in R&D (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Kimberly E Stelzig, Madeline R Pellegrino, Marc Bindzus, Eunhee S Yi, Andrew H Limper
Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2). Drugs in R&D (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Amjad N Kanj, Irene Riestra Guiance, Theodore J Kottom, Kyle J Schaefbauer, Malay Choudhury, Andrew H Limper, Joseph H Skalski
The intestinal commensal fungus Wallemia mellicola enhances asthma in mice through Dectin-2. Medical mycology 62 (2) (2024)
Amjad N Kanj, Irene Riestra Guiance, Theodore J Kottom, Kyle J Schaefbauer, Malay Choudhury, Andrew H Limper, Joseph H Skalski
The intestinal commensal fungus Wallemia mellicola enhances asthma in mice through Dectin-2. Medical mycology 62 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Lung Epithelial Cell Line Immune Responses to Pneumocystis . Journal of fungi (Basel, Switzerland) 9 (7) (2023)
Theodore J Kottom, Kyle Schaefbauer, Eva M Carmona, Eunhee S Yi, Andrew H Limper
Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9. Drugs in R&D 22 (2) (2022)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Gene expression in lung epithelial cells following interaction with Pneumocystis carinii and its specific life forms yields insights into host gene responses to infection. Microbiology and immunology 66 (5) (2022)
Theodore J Kottom, Kyle Schaefbauer, Eva M Carmona, Andrew H Limper
Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina. Pathogens (Basel, Switzerland) 10 (5) (2021)
Theodore J Kottom, Kyle Schaefbauer, Eva M Carmona, Andrew H Limper
EphA2 is a Lung Epithelial Cell Receptor for Pneumocystis β-glucans. The Journal of infectious diseases (2021)
Michael H Bourne, Theodore J Kottom, Deanne M Hebrink, Malay Choudhury, Edward B Leof, Andrew H Limper
Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib. Cells 10 (12) (2021)